Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Jazz Pharmaceuticals plc | Director | Ordinary Shares | 9.14K | $1.02M | $111.35 | Aug 6, 2024 | Direct |
Denali Therapeutics Inc. | Director | Common Stock | 20K | $435K | $21.73 | Jun 6, 2024 | Direct |
BridgeBio Pharma, Inc. | Director | Stock Option (Right to Buy) | 26K | Jun 21, 2024 | Direct | ||
Denali Therapeutics Inc. | Director | Stock Option (right to buy) | 17.9K | May 31, 2024 | Direct |